Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
Keyword(s):
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. e15009-e15009
2013 ◽
Vol 49
(6)
◽
pp. 1205-1215
◽
Keyword(s):
2015 ◽
Vol 25
(6)
◽
pp. 1441-1449
◽
Keyword(s):
2008 ◽
Vol 17
(2)
◽
pp. 207-214
◽